Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 31

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 31
---
, and on June 8, 2023 stockholders approved, Amendment No. 3 to the 2018 Plan to increase the maximum aggregate number of shares of common stock that may be issued under the 2018 Plan by 2,500,000 shares and to provide that the aggregate share reserve under the 2018 Plan should be 13,187,596. On April 11, 2025 the Board approved, subject to stockholder approval, Amendment No. 4 to the 2018 Plan to increase the maximum aggregate number of shares of common stock that may be issued under the 2018 Plan by 4,300,000 shares and to provide that the aggregate share reserve under the 2018 Plan should be 17,487,596, which reflects (i) 4,300,000 new shares subject to this proposal, (ii) 2,500,000 shares approved by the stockholders on June 8, 2023, (iii) 2,500,000 shares approved by the stockholders on June 2, 2022, (iv) 3,800,000 shares approved by the stockholders on June 4, 2020, (v) 2,900,000 shares approved by stockholders on June 6, 2018 and (vi) 1,487,596 shares, which was the maximum number of shares available under the 2011 Plan as of April 11, 2018, plus the number of shares subject to outstanding awards under the 2011 Plan that expire or otherwise terminate without having been exercised in full, or are forfeited to or repurchased by us, up to a maximum of 2,412,466 shares.

As of March 31, 2025, the 2018 Plan had 13,187,596 authorized shares plus any shares subject to options or similar awards under the 2011 Plan that expire or otherwise terminate without having been exercised in full and shares issued pursuant to awards granted under the 2011 Plan that are forfeited to or repurchased by the Company at the original issuance price (up to the maximum described above).

The 2018 Plan permits the grant of the following types of “Awards”: (i) non-statutory stock options that are not intended to qualify for favorable tax treatment under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), incentive stock options that are intended to qualify for favorable tax treatment